Robert Woolson to Clinical Trials as Topic
This is a "connection" page, showing publications Robert Woolson has written about Clinical Trials as Topic.
Connection Strength
0.615
-
Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
Score: 0.187
-
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology. 1993 May; 43(5):1021-7.
Score: 0.079
-
Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9.
Score: 0.061
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.058
-
A rank-based sample size method for multiple outcomes in clinical trials. Stat Med. 2008 Jul 20; 27(16):3084-104.
Score: 0.057
-
A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study. Subst Abuse Treat Prev Policy. 2008 Jun 03; 3:13.
Score: 0.056
-
Sample size for case-control studies using Cochran's statistic. Biometrics. 1986 Dec; 42(4):927-32.
Score: 0.051
-
Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics. 2005 Jun; 61(2):532-9.
Score: 0.046
-
A comparison of two methods of estimating a common risk difference in a stratified analysis of a multicenter clinical trial. Control Clin Trials. 1994 Apr; 15(2):135-53.
Score: 0.021